The main adverse events reported on AIs (anastrozole, letrozole, and exemestane) were decreased libido (27%), arthralgia (24%), mood disorders (12.5%), asthenia (10%), headaches (6%), anxiety (4.5%), and palpitations (3%)
Furthermore, Semaglutide's impact on the central nervous system, particularly the brain's appetite-regulating centers, may further help suppress appetite and promote weight loss
The studys result of increased growth hormone and IGF-1 levels post-administration indicate that CJC-1295 could be a promising candidate
Although these markers are well-established indicators of oxidative stress and cellular status, their improvement may be correlative rather than causative regarding functional protection (Ghezzi et al